Next Generation Pediatric Neuroimaging (NGPN) Development

NIH RePORTER · NIH · R44 · $1,390,948 · view on reporter.nih.gov ↗

Abstract

Pediatric MR imaging is especially difficult due to motion-related artifacts in the images. Often this requires general anesthesia in the clinic, which has been shown recently to be detrimental to brain development. This places unique barriers on assessment of this population for both clinical and research purposes. In this application, we propose the development of the Next Generation Pediatric Neuroimaging (NGPN) technology, which will allow for high quality MR images to be collected in the presence of motion, thereby eliminating the need for general anesthesia while imaging. This technology will provide the MRI contrasts for proton density, T1, T2, T2*, diffusion, perfusion, and fMRI. The NGPN will be achieved by the development of novel hardware (RF coils and T/R switches), imaging sequences, and image reconstruction tools. These advancements will allow clinicians and researchers to image pediatric subjects in a safer, more reliable and efficient manner.

Key facts

NIH application ID
11008691
Project number
2R44MH122028-03A1
Recipient
CHAMPAIGN IMAGING, LLC
Principal Investigator
Curtis Andrew Corum
Activity code
R44
Funding institute
NIH
Fiscal year
2024
Award amount
$1,390,948
Award type
2
Project period
2020-05-01 → 2027-07-31